Jay Pepose

Jay Pepose, listed as board member, appears in our data through filings on Opus Genetics, Inc. shares, published by SEC (Form 4). We count 10 filings; the first trade dates from 13 September 2021 and the latest from 11 June 2024.

Purchases make up the whole of the open-market record (2 purchases, €77k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 share grants.

The record was last updated on 13 June 2024 with a share grant in Opus Genetics, Inc. The last insider purchase was made public on 14 December 2021, 1,769 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.